Immunitybio Inc (IBRX)

Cost of Revenue

$8.91M

TTM · Period ending: · USD

IBRX logo

IBRX Cost of Revenue

Latest reported$8.91M
IBRX TTM Cost of Revenue ($0.00 → $8.91M)
High-resolution chart · PNG

IBRX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Immunitybio Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
8,911,000
8,749,000
8,569,000
4,322,000
194,000
58,000
0
0
0
0
6,278,000
13,156,000
19,131,000
25,062,000
24,192,000
17,314,000
11,339,000
5,408,000
0
2,247,000
2,247,000
2,247,000
2,247,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.